Alexandria Capital’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-26
| Closed | -$2K | – | 268 |
|
|
2017
Q3 | $2K | Sell |
26
-43
| -62% | -$3.31K | ﹤0.01% | 500 |
|
|
2017
Q2 | $6K | Sell |
69
-14
| -17% | -$1.22K | ﹤0.01% | 463 |
|
|
2017
Q1 | $7K | Sell |
83
-4
| -5% | -$337 | ﹤0.01% | 449 |
|
|
2016
Q4 | $7K | Buy |
87
+9
| +12% | +$724 | ﹤0.01% | 446 |
|
|
2016
Q3 | $7K | Buy |
78
+23
| +42% | +$2.06K | ﹤0.01% | 450 |
|
|
2016
Q2 | $4K | Buy |
55
+18
| +49% | +$1.31K | ﹤0.01% | 494 |
|
|
2016
Q1 | $3K | Buy |
37
+10
| +37% | +$811 | ﹤0.01% | 528 |
|
|
2015
Q4 | $3K | Buy |
27
+13
| +93% | +$1.44K | ﹤0.01% | 571 |
|
|
2015
Q3 | $1K | Buy |
+14
| New | +$1K | ﹤0.01% | 560 |
|